Please assess the completion status of the following clinical trial:

Trial Title: Safe and Healthy Schools

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* school children ages 4-19~* MMSD staff~* have at least one symptom of COVID-19~* have not had a positive COVID-19 test in the past 3 months~* will undergo nasal PCR testing at an MMSD elementary school~Exclusion Criteria:~* received a positive COVID-19 test in the past 3 months~Criteria for inclusion in the final study sample:~* Aim 1. Symptomatic participants with a negative at-school BinaxNOW test and nasal PCR results who complete both the lollipop PCR and at-home BinaxNOW tests within 72 hours will be included in the final study sample.~* Aim 2. Symptomatic participants who provide a lollipop swab that is successfully resulted.~Criteria for exclusion in the final study sample:~* Aim 1~  * Missing nasal PCR result~ * Do not successfully complete an at-home BinaxNOW test within 72 hours of the at-school BinaxNOW test~* Aim 2~  * Missing nasal PCR result~ * Missing lollipop PCR result

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- BinaxNOW Test + Lollipop PCR (Type: EXPERIMENTAL): If a symptomatic participant's initial at-school BinaxNOW test was positive, then their study participation is complete after providing the lollipop swab for PCR testing.~If a symptomatic participant's initial at-school BinaxNOW test was negative, then they will be asked to complete an at-home BinaxNOW test approximately 24 hours later.~For the at-home BinaxNOW testing, the participant will schedule a follow-up virtual visit with the study coordinator. If they are unable to complete a virtual visit, they will schedule an in-person home visit. They will also be sent home with a BinaxNOW testing kit.

Based on this trial design, predict the completion outcome and termination type (if applicable).